Qulab Applies Artificial Intelligence To Drug Design
socalTECH
APRIL 24, 2019
Los Angeles-based Qulab , a biopharmaceuticals startup developing artifical intelligence software aimed at small molecule drug design, said on Wednesday that it has launched its first product, Quleap. He also attended USC's Viterbi School of Engineering as a Ph.D.
Let's personalize your content